# Takeda Pharmaceuticals U.S.A.

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/takeda-pharmaceuticals-u-s-a/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | business enterprise in United States of America |
| OpenAlex ID | https://openalex.org/F4320310030 |
| ROR ID | https://ror.org/03bygaq51 |
| Works | 1,891 |

## Funder papers

- [Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study](https://scholariq.org/papers/durvalumab-in-combination-with-olaparib-in-patients-with-relapsed-sclc-results/)
- [Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease](https://scholariq.org/papers/efficacy-and-safety-of-spironolactone-in-patients-with-hfpef-and-chronic-kidney/)
- [Gastric Foveolar Hyperplastic Polyps in 2 Children With Short Bowel Syndrome on Long‐Term Teduglutide](https://scholariq.org/papers/gastric-foveolar-hyperplastic-polyps-in-2-children-with-short-bowel-syndrome-on/)
- [The experience and impact of living with idiopathic hypersomnia: A qualitative study of patient perspectives shared in online media](https://scholariq.org/papers/the-experience-and-impact-of-living-with-idiopathic-hypersomnia-a-qualitative/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.